Dendreon Knocks Shareholders' Push For Equity Committee
Cancer treatment developer Dendreon Corp. urged a Delaware bankruptcy judge Friday to reject a call by shareholders for the formation of an equity committee, saying such a group would only add...To view the full article, register now.
Already a subscriber? Click here to view full article